Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Public ClinicalTrials.gov record NCT06018558. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Study to Assess the Safety And Efficacy Of OCU410 For Geographic Atrophy Secondary To Dry Age-Related Macular Degeneration
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration (AMD). This is a multicenter study, which will be conducted in two phases and will enroll up to a total of 60 subjects.
Study identification
- NCT ID
- NCT06018558
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2023
- Primary completion
- Feb 2, 2026
- Completion
- Feb 2, 2030
- Last update posted
- Jul 30, 2026
2023 – 2030
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Associated Retina Consultants | Phoenix | Arizona | 85020 | — |
| Advanced Research, LLC | Coral Springs | Florida | 33067 | — |
| Miidwest Eye Institute | Carmel | Indiana | 46290 | — |
| Mississippi Retina Associates | Jackson | Mississippi | 39202 | — |
| The Retina Institute | St Louis | Missouri | 63128 | — |
| Mid Atlantic Retina | Cherry Hill | New Jersey | 08034 | — |
| Duke Eye Center | Durham | North Carolina | 27710 | — |
| The University of Pittsburgh | Pittsburgh | Pennsylvania | 15260 | — |
| B) Retina Consultants of Texas | Bellaire | Texas | 77401 | — |
| A) Retina Foundation of the Southwest | Dallas | Texas | 75231 | — |
| Valley retina Institute | McAllen | Texas | 78503 | — |
| Gundersen Health System | La Crosse | Wisconsin | 54601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06018558, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06018558 live on ClinicalTrials.gov.